208 related articles for article (PubMed ID: 2954202)
1. Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus.
Negoro N; Kanayama Y; Takeda T; Amatsu K; Koda S; Inoue Y; Kim T; Okamura M; Inoue T
Rheumatol Int; 1987; 7(1):7-11. PubMed ID: 2954202
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
[TBL] [Abstract][Full Text] [Related]
3. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
5. Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus.
Ahmad A; Brylid A; Dahle C; Saleh M; Dahlström Ö; Enocsson H; Sjöwall C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373545
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
[TBL] [Abstract][Full Text] [Related]
7. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
8. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
[TBL] [Abstract][Full Text] [Related]
9. T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders.
O'Brien RM; Cram DS; Coppel RL; Harrison LC
J Autoimmun; 1990 Dec; 3(6):747-57. PubMed ID: 1708263
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.
Tokano Y; Yasuma M; Harada S; Takasaki Y; Hashimoto H; Okumura K; Hirose S
J Clin Immunol; 1991 Nov; 11(6):317-25. PubMed ID: 1837028
[TBL] [Abstract][Full Text] [Related]
11. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
13. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
Steiner G; Skriner K; Hassfeld W; Smolen JS
Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic challenge of patients with anti-U1-RNP antibodies.
Elhani I; Khoy K; Mariotte D; Comby E; Marcelli C; Le Mauff B; Audemard-Verger A; Boutemy J; Maigné G; Martin Silva N; Aouba A; de Boysson H
Rheumatol Int; 2023 Mar; 43(3):509-521. PubMed ID: 35896805
[TBL] [Abstract][Full Text] [Related]
17. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.
Sato T; Fujii T; Yokoyama T; Fujita Y; Imura Y; Yukawa N; Kawabata D; Nojima T; Ohmura K; Usui T; Mimori T
Arthritis Rheum; 2010 Dec; 62(12):3730-40. PubMed ID: 20722023
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
20. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
